Nantahala Capital Management LLC 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO | Nantahala Capital Management LLC | 4,426,382 9.990% | 1,926,601 (+77.07%) | Filing |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Nantahala Capital Management LLC | 2,499,781 9.900% | 1,140,094 (+83.85%) | Filing |
| 2023-02-14 5:05 pm Purchase | 2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Nantahala Capital Management LLC | 1,359,687 7.900% | 1,359,687 (New Position) | Filing |